Vaccine against COVID-19 or against SARS-CoV-2 infection?

被引：1
|
作者：
Rieske, Piotr [1 ,2 ]
机构：
[1] Uniwersytet Med Lodzi, Zaklad Biol Nowotwordow, Ul Zeligowskiego 7-9, PL-90752 Lodz, Poland
[2] Celther Polska, Lodz, Poland
来源：
ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY | 2020年 / 7卷 / 03期
关键词：
SARS-CoV-2; vaccine; COVID-19; VIRUS; ANTIBODY; NEUTRALIZATION; MECHANISMS; RESPONSES; PARADIGM;
D O I：
10.5114/pja.2020.97913
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine - showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.
引用
收藏
页码：131 / 145
页数：15
相关论文
共 50 条
  • [21] An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
    Kairat Tabynov
    Nurkeldi Turebekov
    Meruert Babayeva
    Gleb Fomin
    Toktassyn Yerubayev
    Tlektes Yespolov
    Lei Li
    Gourapura J. Renukaradhya
    Nikolai Petrovsky
    Kaissar Tabynov
    npj Vaccines, 7
  • [22] An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
    Tabynov, Kairat
    Turebekov, Nurkeldi
    Babayeva, Meruert
    Fomin, Gleb
    Yerubayev, Toktassyn
    Yespolov, Tlektes
    Li, Lei
    Renukaradhya, Gourapura J.
    Petrovsky, Nikolai
    Tabynov, Kaissar
    NPJ VACCINES, 2022, 7 (01)
  • [23] The continued global battle against SARS-CoV-2 and COVID-19
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (06): : 1440 - 1442
  • [24] Detection of antibodies against SARS-CoV-2 in patients with COVID-19
    Du, Zhe
    Zhu, Fengxue
    Guo, Fuzheng
    Yang, Bo
    Wang, Tianbing
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 1735 - 1738
  • [25] Antibody responses against SARS-CoV-2 in COVID-19 patients
    Liu, Anding
    Li, Ying
    Peng, Jing
    Huang, Yuancheng
    Xu, Dong
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 144 - 148
  • [26] Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study
    Gram, Mie Agermose
    Emborg, Hanne-Dorthe
    Schelde, Astrid Blicher
    Friis, Nikolaj Ulrik
    Nielsen, Katrine Finderup
    Moustsen-Helms, Ida Rask
    Legarth, Rebecca
    Lam, Janni Uyen Hoa
    Chaine, Manon
    Malik, Aisha Zahoor
    Rasmussen, Morten
    Fonager, Jannik
    Sieber, Raphael Niklaus
    Stegger, Marc
    Ethelberg, Steen
    Valentiner-Branth, Palle
    Hansen, Christian Holm
    PLOS MEDICINE, 2022, 19 (09)
  • [27] A VACCINE AGAINST SARS-COV-2
    Passi, Gouri Rao
    INDIAN PEDIATRICS, 2020, 57 (06) : 593 - 593
  • [28] Homologous and Heterologous Covid-19 Booster Vaccinations Against SARS-CoV-2 Infection in the Elderly
    Acer, Omer
    Bahce, Yasemin Genc
    Ozudogru, Osman
    CURRENT MICROBIOLOGY, 2024, 81 (07)
  • [29] COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants
    Padasas, Bill Thaddeus
    Espano, Erica
    Kim, Sang-Hyun
    Song, Youngcheon
    Lee, Chong-Kil
    Kim, Jeong-Ki
    IMMUNE NETWORK, 2023, 23 (02)
  • [30] Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
    Harder, Thomas
    Koch, Judith
    Vygen-Bonnet, Sabine
    Kuelper-Schiek, Wiebe
    Pilic, Antonia
    Reda, Sarah
    Scholz, Stefan
    Wichmann, Ole
    EUROSURVEILLANCE, 2021, 26 (35)
12345